ReviewAdvances in therapy2026

Risk of protein intake deficiency during treatment with GLP-1 and GIP/GLP-1 receptor agonists: considerations for secondary sarcopenia.

Konstantinos Prokopidis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.